Acitretin (CAS 55079-83-9): A Key Retinoid in Modern Dermatological Treatments
In the realm of dermatological pharmaceuticals, certain compounds stand out for their significant impact on treating complex skin conditions. Acitretin, with its CAS number 55079-83-9, is one such molecule, recognized as a potent synthetic retinoid. Its role extends beyond direct therapeutic use; it is a vital pharmaceutical intermediate, enabling the development of advanced treatments for severe skin disorders, primarily psoriasis.
Retinoids, a class of compounds structurally related to Vitamin A, are known for their ability to regulate skin cell growth and differentiation. Acitretin specifically targets the abnormal proliferation and keratinization processes that characterize conditions like severe psoriasis. By modulating these cellular activities, Acitretin helps to reverse the symptomatic manifestations, leading to healthier skin. This makes it an invaluable asset for pharmaceutical companies engaged in skin disorder research.
The pharmaceutical industry relies heavily on the consistent supply of high-purity intermediates. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to producing Acitretin that meets rigorous quality standards, ensuring its suitability for pharmaceutical formulation. The journey of Acitretin from synthesis to therapeutic application involves careful consideration of its pharmacological profile, including potential drug interactions and side effects. Understanding the nuances of acitretin dosage and its administration is key to maximizing its therapeutic benefits while minimizing risks.
One of the most critical aspects of Acitretin is its teratogenic nature. This means it carries a significant risk of causing severe birth defects if exposure occurs during pregnancy. Consequently, strict contraindications and pregnancy prevention programs are mandatory for its use. Healthcare providers must thoroughly educate patients about these risks and ensure adherence to contraceptive measures. The safety profile of acitretin, including its well-documented adverse effects, is a subject of ongoing importance in pharmaceutical research and clinical practice.
NINGBO INNO PHARMCHEM CO.,LTD. actively supports the pharmaceutical sector by providing reliable access to Acitretin. Our commitment to quality and safety underpins our role in advancing dermatological therapies, contributing to better patient outcomes for those suffering from debilitating skin conditions.
Perspectives & Insights
Agile Reader One
“In the realm of dermatological pharmaceuticals, certain compounds stand out for their significant impact on treating complex skin conditions.”
Logic Vision Labs
“Acitretin, with its CAS number 55079-83-9, is one such molecule, recognized as a potent synthetic retinoid.”
Molecule Origin 88
“Its role extends beyond direct therapeutic use; it is a vital pharmaceutical intermediate, enabling the development of advanced treatments for severe skin disorders, primarily psoriasis.”